OWCPHARMACeuticalResearch
OWC Pharmaceutical Research Corp. engaged in the business, through its newly-organized, wholly-owned Israeli subsidiary, One Word Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of non-psychoactive medical cannabis specifically designed for the treatment of, among other illnesses/medical conditions, PTSD, diabetes, Parkinson's disease, children's epilepsy, prostate cancer, psoriasis, myeloma and topical treatment of burns. The Company also continues to work closely with GUMI Tel Aviv Ltd, a major, privately-held Israeli technology company, in the manufacture and marketing of commercial model(s) of the Company's Patented Percussion Device. Stand 01.11.2016
WKN: A12HSZ ISIN: US67109N1081 Kürzel: OWCP (OTC) in 
handelbar: NEIN
Gründungsjahr: 2008 Haupthandelsplatz 
Vollzogene Namenswechsel Dynamic Applications Corp., Touchstone Mining Ltd. bis 12-2010 Land 
Angestellte: 5
